Trademarkia Logo

Canada

C$
MIDACORE
REGISTERED

on 19 Mar 2020

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

MIDATECH LIMITED

65 Innovation DriveMilton ParkAbingdonOxfordshire, OX14 4RQ

GB

Serial Number

1883909 filed on 20th Feb 2018

Registration Number

TMA1075535 registered on 19th Mar 2020

Registration expiry Date

19th Mar 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

MIDACORE

Trademark usage description

nanoparticles ingredients for use in the manufacture of pharmaceuticals, medicines and cosmetics; nanoparticles for use as carriers for pharmaceutical Read More

Classification Information


Class [001]
Nanoparticles ingredients for use in the manufacture of pharmaceuticals, medicines and cosmetics; nanoparticles for use as carriers for pharmaceuticals, medicines and cosmetics


Classification kind code

11

Class [005]
Pharmaceuticals and medicines containing nano-particles for the treatment of the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations, and cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles and veterinary vaccines incorporating nano-particles


Classification kind code

11

Class [040]
Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices


Classification kind code

11

Class [042]
Scientific research services in the field of nano-particle technology; pharmaceutical and drug development and discovery services; testing, efficiency and advisory services in the field of design, development and scientific research of nano-particles, pharmaceuticals and nano-medicine; nano-particle laboratory services


Classification kind code

11

Mark Details


Serial Number

1883909

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 22nd Jan 2020
Registration Pending
Submitted for opposition 191
on 22nd Jan 2020
Registration Fee Notice Sent
Submitted for opposition 42
on 30th Oct 2019
Advertised
Submitted for opposition 26
on 10th Oct 2019
Approved
Submitted for opposition 27
on 10th Oct 2019
Approval Notice Sent
Submitted for opposition 22
on 10th Jun 2019
Search Recorded
Submitted for opposition 20
on 10th Jun 2019
Examiner's First Report
Submitted for opposition 31
on 22nd Feb 2018
Formalized
Submitted for opposition 30
on 20th Feb 2018
Filed
Submitted for opposition 1
on 20th Feb 2018
Created